ARCHIVES

UFT – Leucovorin Combo Not A Breakthrough, But could Merit Approval, Committee Says

This article is from The Cancer Letter archive.

Vol. 25 No. 36 | September 24, 1999

Download PDF Visit The Full Archive

Related Articles

NCI’s $65 Million to NTP Will Be Controversial, Untouchable; Spectre Of Another Backlog Looms

February 8, 1980

NIH Deputy Director Ruth Kirschstein Plans Transition To Senior Advisor

October 4, 2002

Robert Weinburger, Ernst Wynder Win Top Milken Awards

November 2, 1990

In Brief: Cooper Resigns From DPC Board, Bettinghaus Names, Chairman; William Dewyus Leaves NCI

September 13, 1985

Generic Paclitaxel Approval Withstands Court Challenge.

May 4, 2001

UNC Oncologist Edison Liu To Direct NCI Intramural Clinical Research Programs

June 28, 1996